Grants and Contributions:
Title:
Sulforaphane manufacturing process enhancement: optimization of myrosinase expression conditions
Agreement Number:
941512
Agreement Value:
$28,586.00
Agreement Date:
Jan 15, 2020 - Apr 30, 2020
Description:
Optimize myrosinase expression conditions in an expression system and develop methods for quantification of activity, yield and purification.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Burnaby, British Columbia, CA V5M 3Z3
Reference Number:
172-2019-2020-Q4-941512
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
821214632
Recipient Type:
For-profit organization
Recipient's Legal Name:
Pharmaplanter Technologies Inc.
Federal Riding Name:
Burnaby South
Federal Riding Number:
59003
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
32541